Roberts, Glore & Co’s Cognizant CTSH Stock Holding History

Roberts, Glore & Co’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,216	Closed	-$267K	–	222
2025 Q4	$267K	Buy	+3,216	New	+$241K	0.07%	184

Other funds holding CTSH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Roberts, Glore & Co's CTSH Position: Q1 2026 in Review

Roberts, Glore & Co sold out of Cognizant (CTSH) in Q1 2026, closing a stake of 3,216 shares — an estimated $267K sold.

Roberts, Glore & Co first reported a position in CTSH in Q4 2025 and held it in 1 quarter. The position peaked at $267K in Q4 2025. 985 funds tracked by Wall St. Rank hold CTSH as of Q1 2026.

Roberts, Glore & Co reported no remaining Cognizant position as of Q1 2026 after selling out during the quarter.
Roberts, Glore & Co sold 3,216 Cognizant shares in Q1 2026, an estimated $267K.
Roberts, Glore & Co first reported a position in Cognizant in Q4 2025 and held it in 1 quarter.
Roberts, Glore & Co's Cognizant position peaked at $267K in Q4 2025.
985 funds tracked by Wall St. Rank held Cognizant as of Q1 2026.

Based on Roberts, Glore & Co's 13F filing for Q1 2026, filed 4 May 2026.